At Janssen, we are creating a future where disease is a thing of the past.
As the pharmaceutical division of Johnson & Johnson, Janssen is one of the world's leading research-based pharmaceutical companies, founded in 1953 by Dr. Paul Janssen in Belgium. Our vision at Janssen is a future in which illnesses are a thing of the past. We therefore work tirelessly to make this future a reality for patients around the world.
We focus on areas of medicine where we can make the biggest difference: haematology, oncology, immunology, neuroscience, pulmonary hypertension and infectious diseases.
Driven by our commitment to patients, Janssen develops innovative products, services and healthcare solutions to help people throughout the world.
This attitude is one of the central values of the Johnson & Johnson Credo , which was founded over 75 years ago.
For more information about Janssen, please visit our website:
EM-70793 - August 2021